Veritas Genetics scores $30 mln Series B
Veritas Genetics, an accessible genetic testing provider, has secured $30 million in Series B funding. Trustbridge Partners led the round with participation from Lilly Asia Ventures and Jiangsu Simcere Pharmaceutical.
17 October 2016•1 min read
